AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34188144 — intervention group
Group type: EXPERIMENTAL
Intervention: Inefficient arsenic metabolism (%MMA) among never-smokers
Number of subjects: 1395
Study 34188144 — intervention group
Group type: EXPERIMENTAL
Intervention: Efficient arsenic metabolism (%DMA) among never-smokers
Number of subjects: 1395
Study 34188144 — intervention group
Group type: EXPERIMENTAL
Intervention: Inefficient arsenic metabolism (%iAs) among ever-smokers
Number of subjects: 1395
Study 34188144 — intervention group
Group type: EXPERIMENTAL
Intervention: Inefficient arsenic metabolism (%MMA) among ever-smokers
Number of subjects: 1395
Study 34188144 — intervention group
Group type: EXPERIMENTAL
Intervention: Efficient arsenic metabolism (%DMA) among ever-smokers
Number of subjects: 1395
Study 32471934 — intervention group
Group type: EXPERIMENTAL
Intervention: Reference ranges based on dyspnoea percentiles (0‐10 Borg scale) established in 275 apparently healthy subjects aged 20‐85 years (131 men).
Number of subjects: 167
Study 32471934 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects with physiological abnormalities known to elicit exertional dyspnoea.
Number of subjects: 167
Study 32471934 — intervention group
Group type: COMPARATOR
Intervention: Validation sample (n=451; 224 men) compared with reference sample.
Number of subjects: 167
Study 35752525 — intervention group
Group type: EXPERIMENTAL
Intervention: SGA with preemptive AWNB
Number of subjects: 90
Study 35752525 — intervention group
Group type: EXPERIMENTAL
Intervention: SGA with preemptive LAI
Number of subjects: 90
Study 35752525 — intervention group
Group type: COMPARATOR
Intervention: Standard General Anesthesia (SGA)
Number of subjects: 90
Study 32170589 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient pharmaceutical care (medication reconciliation, daily pharmacist visits, discharge counseling and education by 2 certified pharmacists)
Number of subjects: 61
Study 32170589 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 61
Study 32170589 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient pharmaceutical care
Number of subjects: 61
Study 35859500 — intervention group
Group type: EXPERIMENTAL
Intervention: Plusoptix
Number of subjects: 2910
Study 35859500 — intervention group
Group type: EXPERIMENTAL
Intervention: 2WIN Adaptica
Number of subjects: 2910
Study 35859500 — intervention group
Group type: COMPARATOR
Intervention: Mohindra retinoscopy
Number of subjects: 2910
Study 34079243 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Ji Quan
Number of subjects: 30
Study 34079243 — intervention group
Group type: COMPARATOR
Intervention: Stretching
Number of subjects: 30
Study 32470312 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES+PRO (neuromuscular electrical stimulation combined with protein supplementation)
Number of subjects: 16
Study 32470312 — intervention group
Group type: COMPARATOR
Intervention: CON (control group)
Number of subjects: 16
Study 35410947 — intervention group
Group type: EXPERIMENTAL
Intervention: Febuxostat treatment
Number of subjects: 204
Study 35410947 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 204
Study 33646060 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP-FG dressing plus oral vitamin E and C
Number of subjects: 25
Study 33646060 — intervention group
Group type: COMPARATOR
Intervention: PRP-FG dressing plus placebo
Number of subjects: 25
Study 32876328 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide 20 mcg
Number of subjects: 41
Study 32876328 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 32876328 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide
Number of subjects: 41
Study 33955249 — intervention group
Group type: EXPERIMENTAL
Intervention: Right arm CGM placement
Number of subjects: 46
Study 33955249 — intervention group
Group type: COMPARATOR
Intervention: Left arm CGM placement
Number of subjects: 46
Study 33955249 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent fasting diet
Number of subjects: 46
Study 33955249 — intervention group
Group type: COMPARATOR
Intervention: Free-living diet
Number of subjects: 46
Study 34798031 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (PrEP delivery integrated in public HIV care clinics)
Number of subjects: 4898
Study 32213642 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg daily aspirin
Number of subjects: 19114
Study 32213642 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19114
Study 35931830 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediguard system
Number of subjects: 20
Study 35931830 — intervention group
Group type: COMPARATOR
Intervention: Free-hand control group
Number of subjects: 20
Study 36029335 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenogeneic collagen matrix (XCM)
Number of subjects: 30
Study 36029335 — intervention group
Group type: COMPARATOR
Intervention: Subepithelial connective tissue graft (SCTG)
Number of subjects: 30
Study 36029335 — intervention group
Group type: EXPERIMENTAL
Intervention: XCM
Number of subjects: 30
Study 36029335 — intervention group
Group type: COMPARATOR
Intervention: SCTG
Number of subjects: 30
Study 36029335 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 33539426 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooperative groups (goal sharing)
Number of subjects: 26
Study 33539426 — intervention group
Group type: COMPARATOR
Intervention: Independent groups (non‐goal sharing)
Number of subjects: 26
Study 35128668 — intervention group
Group type: EXPERIMENTAL
Intervention: Similarity graph algorithm with a 1.5% criterion of similarity and a time window of 2-5 s
Number of subjects: 73
Study 35128668 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional IBI analyses
Number of subjects: 73
Study 34477316 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 20
Study 34477316 — intervention group
Group type: COMPARATOR
Intervention: Spironolactone
Number of subjects: 20
Study 33259459 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP)
Number of subjects: 55
Study 32471387 — intervention group
Group type: EXPERIMENTAL
Intervention: Developmental and Sequenced One‐to‐One Intervention (DS1‐EI)
Number of subjects: 72
Study 32471387 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 72
Study 36070046 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthreshold pan-retinal photocoagulation (S-PRP)
Number of subjects: 35
Study 36070046 — intervention group
Group type: COMPARATOR
Intervention: Threshold pan-retinal photocoagulation (T-PRP)
Number of subjects: 35
Study 32914716 — intervention group
Group type: EXPERIMENTAL
Intervention: Auto-segmentation using FCN-8s network architecture
Number of subjects: 121
Study 32914716 — intervention group
Group type: COMPARATOR
Intervention: Auto-segmentation treating CTV as one anatomical region
Number of subjects: 121
Study 32914716 — intervention group
Group type: EXPERIMENTAL
Intervention: Auto-segmentation treating two parts of CTV as independent regions
Number of subjects: 121
Study 32914716 — intervention group
Group type: COMPARATOR
Intervention: Auto-segmentation
Number of subjects: 121
Study 34058948 — intervention group
Group type: EXPERIMENTAL
Intervention: IM20 × 4
Number of subjects: 273
Study 34058948 — intervention group
Group type: EXPERIMENTAL
Intervention: IM60 × 4
Number of subjects: 273
Study 34058948 — intervention group
Group type: COMPARATOR
Intervention: IM20 × 3
Number of subjects: 273
Study 35565689 — intervention group
Group type: EXPERIMENTAL
Intervention: PFO‐SM (1% PFO, 180 mL/serving)
Number of subjects: 48
Study 35565689 — intervention group
Group type: COMPARATOR
Intervention: SM (Soybean Milk, 180 mL/serving)
Number of subjects: 48
Study 35565689 — intervention group
Group type: COMPARATOR
Intervention: BS‐SM (Black Sesame-Soybean Milk, 180 mL/serving)
Number of subjects: 48
Study 34526698 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA-1273 booster
Number of subjects: 80
Study 34526698 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA-1273.211 booster
Number of subjects: 80
Study 34526698 — intervention group
Group type: EXPERIMENTAL
Intervention: Variant-modified boosters
Number of subjects: 80
Study 34526698 — intervention group
Group type: EXPERIMENTAL
Intervention: All boosters (including mRNA-1273)
Number of subjects: 80
Study 36320174 — intervention group
Group type: EXPERIMENTAL
Intervention: Betahistine 24 mg every 12 hours for 90 days
Number of subjects: 62
Study 36320174 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets every 12 hours for 90 days
Number of subjects: 62
Study 35397165 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg/d, n=40)
Number of subjects: 76
Study 35397165 — intervention group
Group type: COMPARATOR
Intervention: Metformin (1700 mg/d, n=36)
Number of subjects: 76
Study 34615520 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower relative physical capacity group
Number of subjects: 298
Study 34615520 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher relative physical capacity group
Number of subjects: 298
Study 34615520 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher relative physical capacity group (multivariate analysis)
Number of subjects: 298
Study 32735552 — intervention group
Group type: EXPERIMENTAL
Intervention: E2V/LNG IUS
Number of subjects: 79
Study 32735552 — intervention group
Group type: COMPARATOR
Intervention: E2/NETA
Number of subjects: 79
Study 32735552 — intervention group
Group type: COMPARATOR
Intervention: CEE/MPA
Number of subjects: 79
Study 34694249 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided steroid injection targeting both subcompartments (APL and EPB)
Number of subjects: 50
Study 34694249 — intervention group
Group type: COMPARATOR
Intervention: US-guided steroid injection targeting the EPB subcompartment alone
Number of subjects: 50
Study 34694249 — intervention group
Group type: COMPARATOR
Intervention: Comparison of skin hypopigmentation between groups
Number of subjects: 50
Study 32804839 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-step multiple transluminal gateway drainage (MTGD) using two lumen-apposing metal stents (LAMSs)
Number of subjects: 6
Study 35068322 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based cardiac rehabilitation provided by primary care physiotherapists
Number of subjects: 8
Study 33439435 — intervention group
Group type: COMPARATOR
Intervention: Educational eligibility for Autism services
Number of subjects: 283
Study 33439435 — intervention group
Group type: EXPERIMENTAL
Intervention: Autism Diagnostic Observation Schedule, second edition (ADOS-2) classification
Number of subjects: 283
Study 33036537 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) for 30 minutes once daily for 30 days
Number of subjects: 58
Study 35866144 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA (2 mm)
Number of subjects: 52
Study 35866144 — intervention group
Group type: COMPARATOR
Intervention: Biodentine (3 mm)
Number of subjects: 52
Study 33078518 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum tDCS (anodal-1 mA for 20 min)
Number of subjects: 23
Study 33078518 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS (anodal-1 mA for 30 sec)
Number of subjects: 23
Study 33208652 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine gel
Number of subjects: 128
Study 33208652 — intervention group
Group type: COMPARATOR
Intervention: Water-based lubricant
Number of subjects: 128
Study 32032094 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenon (0.25, 0.50, and 0.75 MACawake; 1.30 MACawake for loss of responsiveness)
Number of subjects: 21
Study 32032094 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide (0.25, 0.50, and 0.75 MACawake)
Number of subjects: 21
Study 36085384 — intervention group
Group type: EXPERIMENTAL
Intervention: MAT-2P-LC (2-port laparoscopic cholecystectomy assisted by magnetic anchor technique)
Number of subjects: 60
Study 36085384 — intervention group
Group type: COMPARATOR
Intervention: 3P-LC (conventional 3-port laparoscopic cholecystectomy)
Number of subjects: 60
Study 33171516 — intervention group
Group type: EXPERIMENTAL
Intervention: 17G needle
Number of subjects: 43
Study 33171516 — intervention group
Group type: COMPARATOR
Intervention: 20‐17G needle
Number of subjects: 43
Study 33171516 — intervention group
Group type: EXPERIMENTAL
Intervention: Cohorts with degenerative oocytes
Number of subjects: 43
Study 33171516 — intervention group
Group type: COMPARATOR
Intervention: Cohorts with no degenerative oocytes
Number of subjects: 43
Study 33171516 — intervention group
Group type: COMPARATOR
Intervention: Cohorts without degenerative oocytes
Number of subjects: 43
Study 32058357 — intervention group
Group type: EXPERIMENTAL
Intervention: Velocity-based (VB) training
Number of subjects: 20
Study 32058357 — intervention group
Group type: EXPERIMENTAL
Intervention: Rating of Perceived Exertion (RPE) training
Number of subjects: 20
Study 33764378 — intervention group
Group type: EXPERIMENTAL
Intervention: Helmet noninvasive ventilation (positive end-expiratory pressure, 10-12 cm H2O; pressure support, 10-12 cm H2O) for at least 48 hours
Number of subjects: 109
Study 33764378 — intervention group
Group type: COMPARATOR
Intervention: High-flow nasal oxygen (60 L/min)
Number of subjects: 109
Study 33764378 — intervention group
Group type: EXPERIMENTAL
Intervention: Helmet noninvasive ventilation
Number of subjects: 109
Study 33764378 — intervention group
Group type: COMPARATOR
Intervention: High-flow nasal oxygen
Number of subjects: 109
Study 32222900 — intervention group
Group type: EXPERIMENTAL
Intervention: Software-generated apnea-hypopnea index (sAHI) derived from photoplethysmogram data (PPG)
Number of subjects: 0
Study 36274534 — intervention group
Group type: EXPERIMENTAL
Intervention: Allium hirtifolium bulbs (500 mg twice daily for 6 weeks)
Number of subjects: 49
Study 36274534 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 32631080 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone app intervention
Number of subjects: 191
Study 32631080 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mobile app)
Number of subjects: 191
Study 35725644 — intervention group
Group type: EXPERIMENTAL
Intervention: ADM + self-guided i-CBT
Number of subjects: 3360
Study 35725644 — intervention group
Group type: EXPERIMENTAL
Intervention: ADM + guided i-CBT
Number of subjects: 3360
Study 35725644 — intervention group
Group type: COMPARATOR
Intervention: ADM only
Number of subjects: 3360
Study 32677876 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose (1 × 10^7 cells)
Number of subjects: 22
Study 32677876 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium dose (2 × 10^7 cells)
Number of subjects: 22
Study 32677876 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose (5 × 10^7 cells)
Number of subjects: 22
Study 32677876 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 22
Study 35394359 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback group (tailored feedback: visual diagram, verbal instructions, video examples)
Number of subjects: 23
Study 35394359 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tailored feedback)
Number of subjects: 23
Study 33751917 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic injection of Dextranomer/Hyaluronic Acid (Dx/HA)
Number of subjects: 60
Study 33751917 — intervention group
Group type: COMPARATOR
Intervention: Lich-Gregoir open technique of ureteral reimplantation
Number of subjects: 60
Study 34984626 — intervention group
Group type: EXPERIMENTAL
Intervention: Phacoemulsification and intraocular lens (IOL) implantation
Number of subjects: 78
Study 34033222 — intervention group
Group type: EXPERIMENTAL
Intervention: Reparixin
Number of subjects: 102
Study 34033222 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 32151567 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal-(L)dlPFC/cathodal-(R)vmPFC tDCS
Number of subjects: 15
Study 32151567 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 15
Study 32151567 — intervention group
Group type: EXPERIMENTAL
Intervention: Reversed polarity tDCS
Number of subjects: 15
Study 35279176 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted implementation strategy (educational meeting, ongoing training, workshops, implementation teams, Plan-Do-Study-Act cycles)
Number of subjects: 700
Study 35279176 — intervention group
Group type: COMPARATOR
Intervention: Single implementation strategy (one educational meeting)
Number of subjects: 700
Study 35279176 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted implementation strategy
Number of subjects: 700
Study 35279176 — intervention group
Group type: COMPARATOR
Intervention: Single implementation strategy
Number of subjects: 700
Study 32063251 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory brainstem response (ABR) profiling test for schizophrenia (SZ)
Number of subjects: 16
Study 32063251 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory brainstem response (ABR) profiling test for ADHD
Number of subjects: 16
Study 35965313 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic portfolio
Number of subjects: 90
Study 35965313 — intervention group
Group type: EXPERIMENTAL
Intervention: Online discussion forum
Number of subjects: 90
Study 35965313 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 34115851 — intervention group
Group type: EXPERIMENTAL
Intervention: ZTL-101 (sublingual cannabinoid extract)
Number of subjects: 24
Study 35903418 — intervention group
Group type: EXPERIMENTAL
Intervention: Module intervention (flipchart format)
Number of subjects: 120
Study 35903418 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 120
Study 34257355 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous statin use
Number of subjects: 0
Study 35606221 — intervention group
Group type: EXPERIMENTAL
Intervention: EORTC QLQ-C30 scales
Number of subjects: 0
Study 32191569 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized psychosocial intervention (eight 1-hour weekly sessions plus one booster)
Number of subjects: 173
Study 32191569 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 173
Study 616497272 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous etomidate alone (group E)
Number of subjects: 60
Study 616497272 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous propofol alone (group P)
Number of subjects: 60
Study 616497272 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate combined with propofol (group EP)
Number of subjects: 60
Study 35965066 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 159
Study 35965066 — intervention group
Group type: COMPARATOR
Intervention: Vitamin K Antagonists (VKAs)
Number of subjects: 159
Study 34142409 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic marker localization (MaMaLoc)
Number of subjects: 67
Study 34142409 — intervention group
Group type: COMPARATOR
Intervention: Wire-guided localization (WGL)
Number of subjects: 67
Study 34142409 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 67
Study 36279931 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted, site-specific intervention focused on evidence-based care for patients with T2DM
Number of subjects: 42
Study 36279931 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 42
Study 34424991 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond Universal (SBU; etch‐and‐rinse mode)
Number of subjects: 80
Study 34424991 — intervention group
Group type: COMPARATOR
Intervention: Scotchbond Universal (SBU; self-etch mode)
Number of subjects: 80
Study 34424991 — intervention group
Group type: EXPERIMENTAL
Intervention: OptiBond XTR (OPT; etch‐and‐rinse mode)
Number of subjects: 80
Study 34424991 — intervention group
Group type: COMPARATOR
Intervention: OptiBond XTR (OPT; self-etch mode)
Number of subjects: 80
Study 34424991 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil Universal Bond Quick (CL; etch‐and‐rinse mode)
Number of subjects: 80
Study 34424991 — intervention group
Group type: COMPARATOR
Intervention: Clearfil Universal Bond Quick (CL; self-etch mode)
Number of subjects: 80
Study 34424991 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhese Universal (ADH; etch‐and‐rinse mode)
Number of subjects: 80
Study 34424991 — intervention group
Group type: COMPARATOR
Intervention: Adhese Universal (ADH; self-etch mode)
Number of subjects: 80
Study 32512364 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatty Fish (FF, n=20)
Number of subjects: 79
Study 32512364 — intervention group
Group type: EXPERIMENTAL
Intervention: Camelina sativa oil (CSO, n=18)
Number of subjects: 79
Study 32512364 — intervention group
Group type: EXPERIMENTAL
Intervention: Lean Fish (LF, n=21)
Number of subjects: 79
Study 32512364 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=20)
Number of subjects: 79
Study 35624551 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery group
Number of subjects: 125
Study 35624551 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilatation group
Number of subjects: 125
Study 35624551 — intervention group
Group type: COMPARATOR
Intervention: Reflux group
Number of subjects: 125
Study 33763982 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.2 MHz ultrasound toothbrush
Number of subjects: 50
Study 33763982 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.8 MHz ultrasound toothbrush
Number of subjects: 50
Study 33763982 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.6 MHz ultrasound toothbrush
Number of subjects: 50
Study 32766514 — intervention group
Group type: COMPARATOR
Intervention: 2% Lidocaine with 1:80,000 epinephrine
Number of subjects: 60
Study 32766514 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% Bupivacaine with 1:200,000 epinephrine
Number of subjects: 60
Study 33645416 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based mobile app
Number of subjects: 168
Study 33645416 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person mindfulness-based program (IMBP)
Number of subjects: 168
Study 33645416 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 168
Study 33540157 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusion group (exclusive breastfeeding mothers)
Number of subjects: 88
Study 33170461 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 274
Study 33170461 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 274
Study 32492577 — intervention group
Group type: EXPERIMENTAL
Intervention: Food Insecure Households
Number of subjects: 503